JENNIFER L GOOD
CIK 1229245 · President & CEO · last filed 2026-06-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.27M
Companies
4
Total Filings
49
Lifetime Open-Market Net
-$4.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RYTM | Director | 11,712 | $106.19 | $1.24M | -$4.27M | 13 | 2026-06-25 |
| TRVI | President & CEO | 218,576 | $18.44 | $4.03M | -$195.5K | 19 | 2026-02-20 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 2 | 2018-08-15 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | President & CEO | 18,034 | — | — | $16.1K | 10 | 2010-09-22 |
Recent Filings · Page 2 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-17 | RYTM | Notice (144) | −31,751 | -$1.57M | EDGAR |
| 2024-09-11 | RYTM | Mixed | — | -$1.38M | EDGAR |
| 2024-09-09 | RYTM | Notice (144) | −16,749 | -$824.9K | EDGAR |
| 2024-09-09 | TRVI | Mixed | — | -$9.7K | EDGAR |
| 2024-09-05 | TRVI | Mixed | — | -$91.4K | EDGAR |
| 2024-09-03 | TRVI | Notice (144) | −61,180 | -$193.3K | EDGAR |
| 2024-08-28 | RYTM | Mixed | — | -$455.2K | EDGAR |
| 2024-08-26 | RYTM | Notice (144) | −35,000 | -$1.61M | EDGAR |
| 2024-06-25 | RYTM | Exer (M) | +3,000 | $0 | EDGAR |
| 2024-06-20 | RYTM | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.